Deficiency of Mouse FHR-1 Homolog, FHR-E, Accelerates Sepsis, and Acute Kidney Injury Through Enhancing the LPS-Induced Alternative Complement Pathway

Alternative complement pathway (AP) plays an important role in the development of sepsis, which is life threatening. Deficiency of factor H-related protein 1 (FHR-1), which is a regulator of AP, has been considered as a susceptible factor for atypical hemolytic uremic syndrome (aHUS) and other types...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 11; p. 1123
Main Authors Li, Xiangru, Hao, Zhenhua, Liu, Xiaorong, Li, Wei
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 19.06.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Alternative complement pathway (AP) plays an important role in the development of sepsis, which is life threatening. Deficiency of factor H-related protein 1 (FHR-1), which is a regulator of AP, has been considered as a susceptible factor for atypical hemolytic uremic syndrome (aHUS) and other types of nephropathy when an inducer such as infection exists. However, the underlying mechanism of the disease development is largely unknown. There is no report on gene knockout in any animal infection model and its function is still unclear. Here, a knockout mouse was generated for investigating AP in sepsis and sepsis-induced acute kidney injury (AKI). We found that murine FHR-1 homolog (FHR-E) deficiency enhanced lipopolysaccharide (LPS)-induced AP activation both and and that knockout mice exhibited more severe sepsis and AKI in response to LPS challenge. These results indicated that FHR-E deficiency promoted LPS-induced sepsis and AKI through AP over-activation, providing a mouse model for studying AP regulation and sepsis. This study revealed the function of FHR-E , which may further provide hints to the pathogenesis of FHR-1 deficiency-related diseases by enhancing LPS-induced AP activation.
Bibliography:Edited by: Philippe Saas, INSERM U1098 Interactions Hôte-Greffon-Tumeur & Ingénierie Cellulaire et Génique, France
These authors have contributed equally to this work
This article was submitted to Inflammation, a section of the journal Frontiers in Immunology
Reviewed by: Pilar Sánchez-Corral, University Hospital La Paz Research Institute (IdiPAZ), Spain; Christine Skerka, Leibniz Institute for Natural Product Research and Infection Biology, Germany
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2020.01123